ADIPOQ and hypertensive disorder: The reduction of adiponectin levels displays a central role in obesity, insulin resistance, progression of type 2 diabetes, hypertension, and CVD, while weight loss or caloric restriction leads to increasing adiponectin levels, and this increase is associated with increased insulin sensitivity [32].